Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Carbone

Showing results (151-160 of 181) with videos related to

Pageof 19
Sort By:
The American Journal of Medicine|May 1, 1974
Cavitating splenic infarctionA L Rosenblum, H Bonner, M S Milder, et al.
American Journal of Clinical Oncology|December 1, 1982
Toxicity and response criteria of the Eastern Cooperative Oncology GroupM M Oken, R H Creech, D C Tormey, et al.
Journal of the National Cancer Institute|May 5, 1993
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithineR R Love, P P Carbone, A K Verma, et al.
Cancer Treatment Reports|September 1, 1978
Phase II study of adriamycin and bleomycin in patients with multiple myelomaJ M Bennett, R Silber, E Ezdinli, et al.
Journal of the National Cancer Institute|August 15, 1990
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancerR R Love, P A Newcomb, D A Wiebe, et al.
The New England Journal of Medicine|November 1, 1979
Special report. Steroid receptors in breast cancerE R DeSombre, P P Carbone, E V Jensen, et al.
Cancer Treatment Reports|July 1, 1978
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancerR G Hahn, N R Temkin, E D Savlov, et al.
Cancer Treatment Reports|July 1, 1976
Adriamycin in the treatment of far-advanced lung cancerE W Knight, S Lagakos, L Stolbach, et al.
Annals of Internal Medicine|January 1, 1973
Training program in medical oncologyB J Kennedy, P Calabresi, P P Carbone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Aggressive combined modality therapy for advanced local-regional breast carcinomaC L Loprinzi, P P Carbone, D C Tormey, et al.
Pageof 19

Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
The American Journal of Medicine|May 1, 1974
Cavitating splenic infarctionA L Rosenblum, H Bonner, M S Milder, et al.
American Journal of Clinical Oncology|December 1, 1982
Toxicity and response criteria of the Eastern Cooperative Oncology GroupM M Oken, R H Creech, D C Tormey, et al.
Journal of the National Cancer Institute|May 5, 1993
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithineR R Love, P P Carbone, A K Verma, et al.
Cancer Treatment Reports|September 1, 1978
Phase II study of adriamycin and bleomycin in patients with multiple myelomaJ M Bennett, R Silber, E Ezdinli, et al.
Journal of the National Cancer Institute|August 15, 1990
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancerR R Love, P A Newcomb, D A Wiebe, et al.
The New England Journal of Medicine|November 1, 1979
Special report. Steroid receptors in breast cancerE R DeSombre, P P Carbone, E V Jensen, et al.
Cancer Treatment Reports|July 1, 1978
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancerR G Hahn, N R Temkin, E D Savlov, et al.
Cancer Treatment Reports|July 1, 1976
Adriamycin in the treatment of far-advanced lung cancerE W Knight, S Lagakos, L Stolbach, et al.
Annals of Internal Medicine|January 1, 1973
Training program in medical oncologyB J Kennedy, P Calabresi, P P Carbone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Aggressive combined modality therapy for advanced local-regional breast carcinomaC L Loprinzi, P P Carbone, D C Tormey, et al.
Pageof 19